According to the National Institute of Health, there are more than 500,000 clinical trials happening right now around the world. ChristianaCare has been nationally recognized for contributions to this work, as clinicians and scientists at the Helen F. Graham Cancer Center and Research Institute collaborate to turn laboratory discoveries into real world therapies.
On this week's episode of For The Love of Health, we're joined by Dr. Greg Masters, ChristianaCare’s National Cancer Institute Community Oncology Research Program (NCORP) Principal Investigator. Dr. Masters explains how these vital studies work and why they matter - from testing new medications to exploring innovative treatment combinations, each trial represents hope for patients facing difficult diagnoses.
We're also joined by Robert Robinson, a prostate cancer survivor who himself participated in a clinical trial at ChristianaCare. He shares how his clinical trial not only saved his life, but sparked his mission of talking about men's health.
For its excellence in clinical trials, the Delaware/ChristianaCare NCORP in 2024 earned the prestigious Platinum Award for Exceptional Achievement from the NCI/NCORP.
Gregory A. Masters, M.D., has been a ChristianaCare lung cancer specialist since 2003. In addition to his investigative work with NCORP, Dr. Masters serves as an associate professor at Thomas Jefferson University Medical School in Philadelphia, and is a highly published expert and a reviewer for many of the leading oncology clinical publications.
Links
- ChristianaCare Cancer Clinical Trials
- ChristianaCare News - National Leader in Cancer Clinical Trials: ChristianaCare Advances Pioneering Therapies
- National Institute of Health Clinical Trials Database
- Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer (Robert's clinical trial)
- Robert Robinson's Podcast, The Lions Den
